Exhibit 4.4

FIRST AMENDMENT TO THE CHROMOCELL THERAPEUTICS CORPORATION 

2023 EQUITY INCENTIVE PLAN 

______________________________________________

As adopted by resolution of the 

Board of Directors effective as of February 14, 2024 

______________________________________________

1.                  Section 3 of the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan (the “2023 Plan”) is amended by deleting the number “3,000,000” and inserting therefor “4,000,000”

2.                  Except as hereinabove amended, the provisions of the 2023 Plan shall remain in full force and effect.